A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

New England Journal of Medicine

Volumn 343, Issue 22, 2000, Pages 1586-1593

  Bathon, Joan M ^a,m   Martin, Richard W ^b   Fleischmann, Roy M ^c   Tesser, John R ^d   Schiff, Michael H ^e   Keystone, Edward C ^f   Genovese, Mark C ^g   Wasko, Mary Chester ^h   Moreland, Larry W ⁱ   Weaver, Arthur L ^j   Markenson, Joseph ^k   Finck, Barbara K ^l  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c METROPLEX CLINICAL RESEARCH CENTER   (United States)

^d Phoenix Center for Clinical Research   (United States)

^e Denver Arthritis Clinic   (United States)

^f MOUNT SINAI HOSPITAL   (Canada)

^g STANFORD UNIVERSITY   (United States)

^h UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^j Arthritis Center for Nebraska   (United States)

^k HOSPITAL FOR SPECIAL SURGERY   (United States)

^l AMGEN INC   (United States)

^m JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; GLUCOCORTICOID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; BONE EROSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; JOINT CAVITY; JOINT RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ONSET AGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION;

ADMINISTRATION, ORAL; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; BONE AND BONES; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; JOINTS; MALE; METHOTREXATE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME;

EID: 0034735827     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200011303432201     Document Type: Article

References (32)

1. Detection of tumor necrosis factor α but not tumor necrosis factorβ in rheumatoid arthritis synovial fluid and serum
2. Etanercept in children with polyarticular juvenile rheumatoid arthritis
3. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
4. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
5. Etanercept therapy in rheumatoid arthritis: A randomized, controlled trial
6. How are soluble forms of ICAM-1 (sCD54) and LFA-3 (sCD58) generated?
7. Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor α antibody in rheumatoid arthritis
8. Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis
9. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis
10. Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis
11. Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the cooperative systematic studies of the rheumatic diseases program randomized clinical trial of methotrexate, auranofin, or a combination of the two
12. The effects of drug therapy on radiographic progression of rheumatoid arthritis: Results of a 36-week randomized trial comparing methotrexate and auranofin
13. Methotrexate versus azathioprine in the treatment of rheumatoid arthritis: A forty-eight-week randomized, double-blind trial
14. Remodeling the pyramid or remodeling the paradigms concerning rheumatoid arthritis - Lessons from Hodgkin's disease and coronary artery disease
15. Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression
16. Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug
17. Treatment of rheumatoid arthritis with methotrexate: A prospective open long-term study of 191 cases
18. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis: 84-month update
19. Adverse effects of low dose methotrexate therapy in rheumatoid arthritis
20. Outstanding issues in use of disease-modifying agents in rheumatoid arthritis
21. When does rheumatoid arthritis begin and why do we need to know?
22. Preliminary definition of improvement in rheumatoid arthritis
23. Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?
24. 100 Micron digitization resolution is optimal for x-rays for a large multicenter trial in rheumatoid arthritis (RA)
25. Methods of scoring the progression of radiologic changes in rheumatoid arthritis: Correlation of radiologic, clinical and laboratory abnormalities
26. Biannual radiographic assessments of hands and feet in the three-year prospective followup of patients with early rheumatoid arthritis
27. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?
28. Measurement and prediction of radiological progression in early rheumatoid arthritis
29. Cancer statistics, 1997
30. Remodeling the pyramid - A concept whose time has come
31. Remodelling the pyramid: The therapeutic target of rheumatoid arthritis
32. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis: Towards development of a decision support system